Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Electrotherapy and Intralesional Glucantime for Cutaneous Leishmaniasis
IRCT2016011822583N3Phase 3Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of meglumine antimoniate in cutaneous leishmaniasis (CL) (2 arms), sponsored by North Khorasan University of Medical Sciences. Started Aug 2013; status: completed.
02
Drugs
meglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT2016011822583N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016011822583N3.